Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.

Shuaishuai XuLinping CaoRuyin ChenChanqi YeQiong LiQi JiangFeifei YanMingyu WanXiaochen ZhangJian Ruan

Published in: The oncologist (2024)

These results revealed the differential IDH1 and IDH2 mutation-related landscapes, and we have provided an important reference database to guide ICC treatment.

Keyphrases

wild type
low grade
single cell
emergency department
combination therapy
adverse drug
drug induced